IP Verse

Corticosteroid Containing Orally Disintegrating Tablet Compositions For Eosinophilic Esophagitis - EP3041476

The patent EP3041476 was granted to Adare I on Jan 25, 2023. The application was originally filed on Sep 5, 2014 under application number EP14842811A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP3041476

ADARE I
Application Number
EP14842811A
Filing Date
Sep 5, 2014
Status
Patent Maintained As Amended
Dec 23, 2022
Grant Date
Jan 25, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

DR FALK PHARMAJul 22, 2020LEDERER & KELLER PATENTANWALTE PARTNERSCHAFT MBBADMISSIBLE

Patent Citations (14) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONUS2003115500
DESCRIPTIONUS2003215500
DESCRIPTIONUS2005232988
DESCRIPTIONWO2011041509
INTERNATIONAL-SEARCH-REPORTUS2010215753
INTERNATIONAL-SEARCH-REPORTUS2011081411
INTERNATIONAL-SEARCH-REPORTUS2011097401
OPPOSITIONUS6596311
OPPOSITIONWO2004091585
OPPOSITIONWO2009064457
OPPOSITIONWO2009086046
OPPOSITIONWO2010144865
OPPOSITIONWO2011041509
OPPOSITIONWO2015035114

Non-Patent Literature (NPL) Citations (6) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- AHMAD H.SHAH N., "Formulation of low dose medicines-Theory and Practice", Amer, Pharm. Rev, (20000000), vol. 3, no. 3, pages 1 - 5-
DESCRIPTION- MCGINITY S. W. et al., "Dissolution and uniformity properties of ordered mixes of micronized griseofulvin and a directly compressible excipient", Drug Development and Industrial Pharmacy, (19850000), vol. 11, no. 4, pages 891 - 900-
DESCRIPTION- YALKOWSKY S.H.BOLTON S., "Particle size and content uniformity", Pharmaceutical Research, (19900000), vol. 7, no. 9, pages 962 - 966-
OPPOSITION- Moreton Christian R, "Chapter 6: Disintegrants in Tableting", Pharmaceutical Dosage Forms: Tablets, Vol. 2, (20080101), pages 217 - 249, XP055782094-
OPPOSITION- Webb Paul A, "Surface Area Porosity and Related Physical Characteristics", Pharmaceutical Dosage Forms: Tablets 3rd Edition, (20080101), pages 277 - 302, XP055782087-
SEARCH- DILGER KARIN ET AL, "Active Eosinophilic Esophagitis Is Associated with Impaired Elimination of Budesonide by Cytochrome P450 3A Enzymes", DIGESTION, S. KARGER AG., BASEL, CH, (20130401), vol. 87, no. 2, ISSN 0012-2823, pages 110 - 117, XP008183704 [A] 1-19 * abstract * * page 111, column l, paragraph 4 - paragraph 5 * * page 111, column r, paragraph 2 * * page 115, column r, paragraph 2 - page 116 *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents